7551 - 7575 of 8823 Results
Title
Year
-
RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
-
OPENTitle: Parkinsonism as a Sequela of SARS‐CoV‐2 Infection: Pure Hypoxic Injury or Additional COVID‐19‐Related Response?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1483End Page: 1484Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28656Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28656Citation Count: 23
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 40
-
OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/dc04516a-d43f-4a65-914b-0c5d09b9e5d8Citation Count: 39
-
RESTRICTEDTitle: Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric SignsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2888End Page: 2900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28722Citation Count: 74
-
OPENTitle: Parkinson's Disease and COVID‐19: Do We Need to Be More Patient?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 277End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28469Citation Count: 13
-
RESTRICTEDTitle: Access and Attitudes Toward Palliative Care Among Movement Disorders CliniciansJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 182End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28773Citation Count: 34
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment2021OPENTitle: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression TreatmentJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2549End Page: 2558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11822725Citation Count: 48
-
OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://doi.org/10.1002/mds.28749Citation Count: 34
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 24
- Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial2021RESTRICTEDTitle: Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2693End Page: 2698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28759Citation Count: 41
-
OPENTitle: Parkinson's Kinesia Paradoxa Is Not a ParadoxJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1115End Page: 1118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28550Citation Count: 33
- Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating2021RESTRICTEDTitle: Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical RatingJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2962End Page: 2963Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28776Citation Count: 9
-
RESTRICTEDTitle: Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2419End Page: 2425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28712Citation Count: 24
-
RESTRICTEDTitle: Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP‐RS and vPSPJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2449End Page: 2451Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28757Citation Count: 0
- Reply to: “α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”2021RESTRICTEDTitle: Reply to: “α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2212End Page: 2213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28742Citation Count: 1
-
RESTRICTEDTitle: Mendelian Randomization Studies: A Path to Better Understand Sex and Gender Differences in Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2220End Page: 2222Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28765Citation Count: 5
-
RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
-
RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
RESTRICTEDTitle: Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28588Citation Count: 0
-
RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0
- Moving From Wired to Wireless Brain Stimulation to Treat Movement Disorders: Are We Breaking Ground?2021RESTRICTEDTitle: Moving From Wired to Wireless Brain Stimulation to Treat Movement Disorders: Are We Breaking Ground?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 610End Page: 610Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28499Citation Count: 0
-
RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
-
OPENTitle: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1216End Page: 1228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28472Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28472Citation Count: 73
- Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's Disease2021OPENTitle: Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1967End Page: 1972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28640Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9017317Citation Count: 12